Atai Beckley N.V.

Nasdaq:ATAI

Pharmaceutical Preparations·AMSTELVEEN

atai Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. It was founded in 2018 and is headquartered in Berlin, Germany.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/17/25	→
10-Q/A	Q3 2024	9/30/24	11/14/24	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/12/25	Q4 FY2025	→
10/20/25	Q3 FY2025	→
8/14/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/17/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
↓

News (8-K)

43 shown

Filed	Type	Description
12/5/25	Other	Other Events	→
11/5/25	Other	Other Events	→
11/5/25	Acquisition	Completion of Acquisition or Disposition of Assets	→
11/4/25	Vote	Submission of Matters to a Vote of Security Holders	→
10/27/25	Agreement	Entry into a Material Definitive Agreement	→
10/21/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

20 shown

Filed	Form	Description
12/31/25	POSASR	POSASR	→
12/31/25	S-8 POS	S-8 POS	→
12/5/25	424B7	424B7	→
11/5/25	424B7	427B7	→
10/17/25	424B5	424B5	→
10/16/25	424B5	425B5	→
↓

Filing History(327 filings)

TypeDateAccessionPeriodSize

144

Feb 26, 2026

0001972481-26-000069

—

4.5 KB

15-12G

Dec 31, 2025

0001140361-25-04693215-12G

—

11.4 KB

POSASR

Dec 31, 2025

0001140361-25-046929POSASR

—

16.6 KB

S-8 POS

Dec 31, 2025

0001140361-25-046923S-8 POS

—

456.8 KB

8-K

Dec 5, 2025

0001140361-25-0445798-K

Dec 5, 2025

304.7 KB

424B7

Dec 5, 2025

0001140361-25-044570424B7

—

1.6 MB

Nov 26, 2025

0001140361-25-043536FORM 4

Nov 25, 2025

7.7 KB

10-Q

Nov 12, 2025

0001193125-25-27758310-Q

Sep 30, 2025

22.6 MB

8-K

Nov 12, 2025

0001140361-25-0415468-K

Nov 12, 2025

348.1 KB

Nov 6, 2025

0001140361-25-040856FORM 4

Nov 5, 2025

11.9 KB

Nov 6, 2025

0001140361-25-040854FORM 4

Nov 5, 2025

9.4 KB

Nov 6, 2025

0001140361-25-040852FORM 4

Nov 4, 2025

5.2 KB

Nov 6, 2025

0001140361-25-040850FORM 3

Nov 5, 2025

10.9 KB

Nov 6, 2025

0001140361-25-040848FORM 3

Nov 5, 2025

12.7 KB

8-K

Nov 5, 2025

0001140361-25-0404448-K

Nov 5, 2025

813.5 KB

424B7

Nov 5, 2025

0001140361-25-040439427B7

—

757.2 KB

8-K

Nov 5, 2025

0001140361-25-0404298-K

Nov 5, 2025

205.5 KB

8-K

Nov 4, 2025

0001140361-25-0403588-K

Nov 4, 2025

183.6 KB

SCHEDULE 13D/A

Oct 29, 2025

0001140361-25-039738

—

8.1 KB

425

Oct 27, 2025

0001140361-25-039318425

—

81.3 KB

8-K

Oct 27, 2025

0001140361-25-039317FORM 8-K

Oct 23, 2025

241.1 KB

8-K

Oct 21, 2025

0001140361-25-0387488-K

Oct 20, 2025

188.3 KB

SCHEDULE 13D/A

Oct 20, 2025

0001193125-25-243544

—

238.6 KB

8-K

Oct 20, 2025

0001140361-25-0385258-K

Oct 16, 2025

624.1 KB

424B5

Oct 17, 2025

0001140361-25-038496424B5

—

986.9 KB

25 filings shown

Filed	Form	Description
10/16/25	DEFA14A	DEFA14A	→
10/10/25	DEFA14A	DEFA14A	→
9/29/25	DEFA14A	DEFA14A	→
9/24/25	DEFM14A	DEFM14A	→
9/23/25	DEFA14A	DEFA14A	→
8/14/25	DEFA14A	DEFA14A	→
↓

Atai Beckley N.V.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(327 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/26/25	4	4	→
11/6/25	4	4	→
11/6/25	4	4	→
11/6/25	4	4	→
11/6/25	3	FORM 3	→
11/6/25	3	FORM 3	→
↓

Filed	Form	Description
2/26/26	144	144	→
12/31/25	15-12G	15-12G	→
10/29/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
10/27/25	425	425	→
10/20/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/18/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
↓